Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giovanna.gallo@uniroma1.it
Giovanna Gallo
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
giovanna.gallo@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Hypertension, coronary artery disease and myocardial ischemic syndromes
VASCULAR PHARMACOLOGY
2023
An Expert Opinion on the Role of the Rosuvastatin/Amlodipine Single Pill Fixed Dose Combination in Cardiovascular Prevention
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2023
Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention (SIPREC)
FRONTIERS IN CARDIOVASCULAR MEDICINE
2023
BNP/NT-proBNP levels are sensitive markers of impaired prognosis in patients without heart failure
JACC. ADVANCES
2023
The natriuretic peptides for hypertension treatment
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2022
Endothelial Dysfunction in Hypertension. Current Concepts and Clinical Implications
FRONTIERS IN MEDICINE
2022
Hypertension and COVID-19. Current Evidence and Perspectives
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2022
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy
HEART
2022
Relationship Between Cardiorespiratory Fitness, Baseline Blood Pressure and Hypertensive Response to Exercise in the Ferrari Corporate Population
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2022
Impact of a NDUFC2 Variant on the Occurrence of Acute Coronary Syndromes
FRONTIERS IN CARDIOVASCULAR MEDICINE
2022
Myocardial Infarction in Patients Without Cardiovascular Risk Factors: Advanced Prediction Models to Unlock the Clinical Dilemma?
JACC. CARDIOVASCULAR INTERVENTIONS
2022
β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality
REVIEWS IN CARDIOVASCULAR MEDICINE
2022
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations
VASCULAR HEALTH AND RISK MANAGEMENT
2022
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
2022
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
2022
Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination
JOURNAL OF CARDIOVASCULAR MEDICINE
2022
Endocrine functions of the heart: from bench to bedside
EUROPEAN HEART JOURNAL
2022
Updated Recommendations on Cardiovascular Prevention in 2022. An Executive Document of the Italian Society of Cardiovascular Prevention
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2022
Correction to .updated recommendations on cardiovascular prevention in 2022: an executive document of the italian society of cardiovascular prevention
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2022
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2021
« prima
< precedente
1
2
3
4
5
seguente ›
ultima »
Gruppi di ricerca
Ipertensione arteriosa e prevenzione cardiovascolare
Disregolazione neurormonale nelle malattie cardiovascolari
Disfunzione mitocondriale e stress ossidativo nelle malattie cardiovascolari
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma